Positive correlation between vitreous levels of advanced glycation end products and vascular endothelial growth factor in patients with diabetic retinopathy sufficiently treated with photocoagulation
- 23 February 2007
- journal article
- letter
- Published by BMJ in British Journal of Ophthalmology
- Vol. 91 (3) , 397-398
- https://doi.org/10.1136/bjo.2006.100198
Abstract
Vascular endothelial growth factor (VEGF) elicits retinal vascular hyperpermeability, thrombosis and angiogenesis, having a central role in the pathogenesis of diabetic retinopathy.1 Furthermore, vitreous VEGF levels are increased in proliferative diabetic retinopathy, whereas the levels are decreased after treatment with …Keywords
This publication has 6 references indexed in Scilit:
- Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic StrategyCurrent Pharmaceutical Design, 2005
- Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathyBritish Journal of Ophthalmology, 2005
- Advanced Glycation End Products-Induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor in Bovine Retinal PericytesBiochemical and Biophysical Research Communications, 2002
- Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic RetinopathyOphthalmologica, 2001
- Intravitreous Injections of Vascular Endothelial Growth Factor Produce Retinal Ischemia and Microangiopathy in an Adult PrimateOphthalmology, 1996
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994